Details

Autor(en) / Beteiligte

• Hill, Catherine L
• Rowett, Debra
• Dartnell, Jonathan

Titel

Improving the quality use of highly specialised drugs

Ist Teil von

• Australian prescriber, 2021-10, Vol.44 (5), p.144-145

Ort / Verlag

Melbourne: Therapeutic Guidelines Limited

Erscheinungsjahr

2021

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Highly specialised drugs, such as biological therapies, are an increasing challenge for the quality use of medicines (QUM). QUM is a central objective of Australia’s National Medicines Policy. The National Strategy for Quality Use of Medicines aims to make the best possible use of medicines to improve health outcomes for all Australians.1To improve QUM the Australian Government has been funding the National Prescribing Service (now called NPS MedicineWise) since 1998 to design, develop, implement and evaluate national programs. From inception, specialist physicians have contributed to NPS MedicineWise programs, for example in developing and endorsing key messages. However, the prescribers of highly specialised drugs have not been a key audience for QUM interventions.A wide range of interventions has emerged to promote the uptake of research findings and evidence-based practices into routine care.2 Given their variable success, research continues with a focus on improving the understanding of how to design and evaluate interventions, and identifying factors that modify their effectiveness.